Profile
Full Name
Cellectar Biosciences, Inc.Ticker Symbol
CLRBExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
November 10, 2005Indexes
Not includedWebsite
http://www.cellectar.comEmployees
11Key Details
Price
$0.30(+6.79%)
Market cap
$13.78M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.40(+60.00% YoY)
PE ratio
-
Next earnings date
May 14, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Cellectar Biosciences doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Dec 11, 24 Oppenheimer
PerformNov 19, 24 Oppenheimer
OutperformMar 28, 24 Roth MKM
BuyMar 28, 24 Oppenheimer
OutperformMar 4, 24 Roth MKM
BuyNov 4, 22 HC Wainwright & Co.
BuyNov 25, 20 Roth Capital
BuyNov 25, 20 Oppenheimer
OutperformNov 25, 20 Maxim Group
BuyNov 25, 20 Ladenburg Thalmann
BuyInstitutional Ownership
- What is the ticker symbol for Cellectar Biosciences?
- Does Cellectar Biosciences pay dividends?
- What sector is Cellectar Biosciences in?
- What industry is Cellectar Biosciences in?
- What country is Cellectar Biosciences based in?
- When did Cellectar Biosciences go public?
- Is Cellectar Biosciences in the S&P 500?
- Is Cellectar Biosciences in the NASDAQ 100?
- Is Cellectar Biosciences in the Dow Jones?
- When was Cellectar Biosciences's last earnings report?
- When does Cellectar Biosciences report earnings?
- Should I buy Cellectar Biosciences stock now?
What is the ticker symbol for Cellectar Biosciences?
The ticker symbol for Cellectar Biosciences is NASDAQ:CLRB
Does Cellectar Biosciences pay dividends?
No, Cellectar Biosciences does not pay dividends
What sector is Cellectar Biosciences in?
Cellectar Biosciences is in the Healthcare sector
What industry is Cellectar Biosciences in?
Cellectar Biosciences is in the Biotechnology industry
What country is Cellectar Biosciences based in?
Cellectar Biosciences is headquartered in United States
When did Cellectar Biosciences go public?
Cellectar Biosciences's initial public offering (IPO) was on November 10, 2005
Is Cellectar Biosciences in the S&P 500?
No, Cellectar Biosciences is not included in the S&P 500 index
Is Cellectar Biosciences in the NASDAQ 100?
No, Cellectar Biosciences is not included in the NASDAQ 100 index
Is Cellectar Biosciences in the Dow Jones?
No, Cellectar Biosciences is not included in the Dow Jones index
When was Cellectar Biosciences's last earnings report?
Cellectar Biosciences's most recent earnings report was on Mar 13, 2025
When does Cellectar Biosciences report earnings?
The next expected earnings date for Cellectar Biosciences is May 14, 2025
Should I buy Cellectar Biosciences stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions